253 related articles for article (PubMed ID: 10389593)
21. Self-cleaving-ribozyme-mediated reduction of betaAPP in human rhabdomyosarcoma cells.
Dolzhanskaya N; Conti J; Schwenk V; Merz G; Denman RB
Arch Biochem Biophys; 2001 Mar; 387(2):223-32. PubMed ID: 11370845
[TBL] [Abstract][Full Text] [Related]
22. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
23. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
24. An allele-specific hammerhead ribozyme gene therapy for a porcine model of autosomal dominant retinitis pigmentosa.
Shaw LC; Skold A; Wong F; Petters R; Hauswirth WW; Lewin AS
Mol Vis; 2001 Jan; 7():6-13. PubMed ID: 11172137
[TBL] [Abstract][Full Text] [Related]
25. In vivo silencing of the human gamma-globin gene in murine erythroid cells following retroviral transduction.
Lung HY; Meeus IS; Weinberg RS; Atweh GF
Blood Cells Mol Dis; 2000 Dec; 26(6):613-9. PubMed ID: 11358353
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach.
Gorbatyuk MS; Pang JJ; Thomas J; Hauswirth WW; Lewin AS
Mol Vis; 2005 Aug; 11():648-56. PubMed ID: 16145542
[TBL] [Abstract][Full Text] [Related]
27. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of white gene expression in transgenic Drosophila melanogaster: possible role of a catalytic antisense RNA.
Heinrich JC; Tabler M; Louis C
Dev Genet; 1993; 14(4):258-65. PubMed ID: 7693385
[TBL] [Abstract][Full Text] [Related]
29. Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme.
Bi F; Fan D; Hui H; Wang C; Zhang X
Cancer Gene Ther; 2001 Nov; 8(11):835-42. PubMed ID: 11773973
[TBL] [Abstract][Full Text] [Related]
30. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
Cai DW; Mukhopadhyay T; Roth JA
Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
[TBL] [Abstract][Full Text] [Related]
31. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
32. High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.
Fabry ME; Nagel RL; Pachnis A; Suzuka SM; Costantini F
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12150-4. PubMed ID: 1465454
[TBL] [Abstract][Full Text] [Related]
33. Proper developmental control of human globin genes reproduced by transgenic mice containing a 160-kb BAC carrying the human beta-globin locus.
Huang Y; Liu DP; Wu L; Li TC; Wu M; Feng DX; Liang CC
Blood Cells Mol Dis; 2000 Dec; 26(6):598-610. PubMed ID: 11358351
[TBL] [Abstract][Full Text] [Related]
34. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
35. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell line.
Zoueva OP; Rodgers GP
Exp Hematol; 2004 Aug; 32(8):700-8. PubMed ID: 15308321
[TBL] [Abstract][Full Text] [Related]
37. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
Davies G; Watkins G; Mason MD; Jiang WG
Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
Sadelain M
Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
[TBL] [Abstract][Full Text] [Related]
39. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced in vivo sickling of transgenic mouse red cells.
Rubin EM; Witkowska HE; Spangler E; Curtin P; Lubin BH; Mohandas N; Clift SM
J Clin Invest; 1991 Feb; 87(2):639-47. PubMed ID: 1991848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
